TrialBMC infectious diseases2025

Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials.

Cissy M Kityo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.